Valproate is a commonly prescribed anticonvulsant used in the treatment of seizure and bipolar disorders. Valproate has also been utilized for the treatment of migraine headaches and in the the setting of bipolar disorder. Valproate is an antiepileptic drug with a broad mechanism of action. This CME activity reviews the etiology, epidemiology, mechanism of action, pathophysiology, toxicokinetic, and histopathology of valproate toxicity. This activity will focus on physical examination, diagnosis, management, and prognosis of Valproate toxicity in clinical settings. It also emphasizes patient education and the interprofessional team-based approach necessary for patient-centered care.

**Objectives:**
- Identify the etiology of valproate toxicity. 
- Review the steps in the evaluation of valproate toxicity.
- Outline the management options available for valproate toxicity.
- Describes interprofessional team strategies for improving care coordination and communication to advance and improve outcomes for patients with valproate toxicity.